1 INTRODUCTION 37
1.1 STUDY OBJECTIVES 37
1.2 MARKET DEFINITION 37
1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY 38
1.3 MARKETS COVERED 38
1.3.1 MARKET SEGMENTATION 38
1.3.2 REGIONAL SCOPE 39
1.3.3 YEARS CONSIDERED 39
1.4 CURRENCY 40
1.5 LIMITATIONS 40
1.6 STAKEHOLDERS 40
1.7 SUMMARY OF CHANGES 41
1.8 RECESSION IMPACT 41
2 RESEARCH METHODOLOGY 42
2.1 RESEARCH DATA 42
2.2 RESEARCH APPROACH 42
FIGURE 1 WOUND CARE MARKET: RESEARCH DESIGN 42
2.2.1 SECONDARY DATA 43
2.2.1.1 Key data from secondary sources 43
2.2.2 PRIMARY DATA 44
2.2.2.1 Primary sources 44
2.2.2.2 Key data from primary sources 45
2.2.2.3 Key industry insights 46
2.2.2.4 Breakdown of primary interviews 46
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 46
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 47
2.3 MARKET SIZE ESTIMATION 47
2.3.1 BOTTOM-UP APPROACH 48
2.3.1.1 Approach 1: Company revenue estimation approach 48
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 48
2.3.1.2 Approach 2: Presentations of companies and primary interviews 48
2.3.1.3 Growth forecast 49
2.3.1.4 CAGR projections 49
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 49
2.3.2 TOP-DOWN APPROACH 50
FIGURE 6 WOUND CARE MARKET: TOP-DOWN APPROACH 50
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 51
FIGURE 7 DATA TRIANGULATION METHODOLOGY 51
2.5 MARKET SHARE 52
2.6 STUDY ASSUMPTIONS 52
2.7 RISK ASSESSMENT 53
2.8 METHODOLOGY & SCOPE-RELATED LIMITATIONS 53
2.9 GROWTH RATE ASSUMPTIONS 53
2.10 RECESSION IMPACT ON WOUND CARE MARKET 54
3 EXECUTIVE SUMMARY 55
FIGURE 8 WOUND CARE MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION) 55
FIGURE 9 WOUND CARE MARKET, BY WOUND TYPE, 2023 VS. 2028 (USD MILLION) 56
FIGURE 10 WOUND CARE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 56
FIGURE 11 WOUND CARE MARKET, BY REGION, 2023 VS. 2028 (USD MILLION) 57
4 PREMIUM INSIGHTS 58
4.1 WOUND CARE MARKET OVERVIEW 58
FIGURE 12 GROWING PREVALENCE OF DISEASES & HEALTH CONDITIONS THAT AFFECT WOUND HEALING CAPABILITIES TO DRIVE MARKET 58
4.2 WOUND CARE MARKET SHARE, BY PRODUCT, 2023 VS. 2028 59
FIGURE 13 ADVANCED WOUND CARE PRODUCTS SEGMENT TO DOMINATE MARKET IN 2028 59
4.3 WOUND CARE MARKET SHARE, BY WOUND TYPE, 2023 VS. 2028 59
FIGURE 14 CHRONIC WOUNDS SEGMENT DOMINATES MARKET DURING FORECAST PERIOD 59
4.4 WOUND CARE MARKET SHARE, BY END USER, 2023 VS. 2028 60
FIGURE 15 HOSPITALS & CLINICS WILL CONTINUE TO DOMINATE MARKET IN 2028 60
4.5 WOUND CARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 60
FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 60
5 MARKET OVERVIEW 61
5.1 INTRODUCTION 61
5.2 MARKET DYNAMICS 61
FIGURE 17 WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 61
5.2.1 DRIVERS 62
5.2.1.1 Growing prevalence of diseases & health conditions that affect wound healing capabilities 62
5.2.1.1.1 Growing geriatric population 62
5.2.1.1.2 Rising prevalence of diabetes 63
FIGURE 18 PREVALENCE OF DIABETES IN ADULTS (20–79 YEARS), BY REGION, 2021 VS. 2045 (MILLION CASES) 63
TABLE 1 TOTAL HEALTH EXPENDITURE DUE TO DIABETES (20–79 YEARS), BY COUNTRY, 2021 63
5.2.1.1.3 Increasing number of surgical procedures worldwide 64
5.2.1.2 Rising expenditure on chronic wounds 64
5.2.1.3 Increasing incidence of burn injuries 65
5.2.1.4 Rising cases of traumatic injuries 65
TABLE 2 PREVALENCE OF ROAD ACCIDENTS 66
5.2.1.5 Technological advancements in wound care products 66
5.2.1.6 Rising use of regenerative medicine for wound management 67
5.2.2 RESTRAINTS 67
5.2.2.1 High cost of advanced wound care products 67
TABLE 3 AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS 68
5.2.2.2 Risks associated with use of advanced wound care products 68
TABLE 4 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS 68
5.2.3 OPPORTUNITIES 68
5.2.3.1 Growth potential of emerging countries 68
TABLE 5 STRATEGIC DEVELOPMENTS IN ASIA PACIFIC REGION 69
5.2.4 CHALLENGES 70
5.2.4.1 Growing instances of product recalls by regulatory bodies 70
5.2.4.2 Dearth of awareness 70
5.3 PRICING ANALYSIS 70
TABLE 6 AVERAGE SELLING PRICE OF KEY PRODUCTS IN WOUND CARE MARKET (2022) 70
TABLE 7 AVERAGE SELLING PRICE TRENDS, BY REGION, 2022 71
5.4 PATENT ANALYSIS 72
FIGURE 19 PATENT ANALYSIS OF WOUND CARE MARKET, JANUARY 2013–DECEMBER 2022 72
5.4.1 LIST OF MAJOR PATENTS 73
5.5 VALUE CHAIN ANALYSIS 74
FIGURE 20 VALUE CHAIN ANALYSIS OF WOUND CARE MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 74
5.6 SUPPLY CHAIN ANALYSIS 75
FIGURE 21 WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS 75
5.7 ECOSYSTEM ANALYSIS 76
FIGURE 22 WOUND CARE MARKET: ECOSYSTEM ANALYSIS 76
5.7.1 WOUND CARE MARKET: ROLE IN ECOSYSTEM 77
5.8 PORTER’S FIVE FORCES ANALYSIS 77
TABLE 8 WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS 77
5.8.1 THREAT OF NEW ENTRANTS 78
5.8.2 THREAT OF SUBSTITUTES 78
5.8.3 BARGAINING POWER OF BUYERS 78
5.8.4 BARGAINING POWER OF SUPPLIERS 78
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 78
5.9 REGULATORY LANDSCAPE 78
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 79
TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
TABLE 12 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 80
5.9.1 NORTH AMERICA 80
5.9.1.1 US 80
5.9.1.2 Canada 80
5.9.2 EUROPE 81
5.9.3 ASIA PACIFIC 81
5.9.3.1 China 81
5.9.3.2 Japan 81
5.9.3.3 India 81
5.9.4 LATIN AMERICA 81
5.9.4.1 Brazil 81
5.9.4.2 Mexico 82
5.9.5 MIDDLE EAST 82
5.9.6 AFRICA 82
5.10 PESTEL ANALYSIS 83
5.11 TRADE ANALYSIS 84
5.11.1 TRADE ANALYSIS FOR ADHESIVE DRESSINGS 84
TABLE 13 IMPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY, 2018–2022 (USD MILLION) 84
TABLE 14 EXPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY, 2018–2022 (USD MILLION) 84
5.12 TECHNOLOGY ANALYSIS 85
5.13 KEY CONFERENCES & EVENTS IN 2023–2024 85
TABLE 15 WOUND CARE MARKET: DETAILED LIST OF CONFERENCES & EVENTS 85
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 87
5.14.1 REVENUE SOURCES SHIFTING TOWARD TECHNOLOGY-BASED SOLUTIONS DUE TO COVID-19 PANDEMIC 87
5.14.2 REVENUE SHIFT IN WOUND CARE MARKET 88
5.15 KEY STAKEHOLDERS & BUYING CRITERIA 88
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 88
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF WOUND CARE PRODUCTS 88
TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF WOUND CARE PRODUCTS (%) 89
5.15.2 BUYING CRITERIA 89
FIGURE 24 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS 89
TABLE 17 KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS 89
5.16 CASE STUDY ANALYSIS 90
5.16.1 CASE STUDY: SURGICAL WOUND TURNS AROUND IN 3 WEEKS 90
6 WOUND CARE MARKET, BY PRODUCT 91
6.1 INTRODUCTION 92
TABLE 18 WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 92
6.1.1 PRIMARY NOTES 92
6.1.1.1 Key industry insights 92
6.2 ADVANCED WOUND CARE PRODUCTS 92
TABLE 19 ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 20 ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 93
6.2.1 ADVANCED WOUND DRESSINGS, BY TYPE 94
TABLE 21 ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 94
TABLE 22 ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
6.2.1.1 Foam dressings 95
TABLE 23 KEY PRODUCTS IN FOAM DRESSINGS MARKET 96
TABLE 24 FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 96
TABLE 25 FOAM DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 97
6.2.1.1.1 Silicone dressings 97
6.2.1.1.1.1 Help expedite wound closure and reduce risk of maceration 97
TABLE 26 SILICONE DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 98
6.2.1.1.2 Non-silicone dressings 98
6.2.1.1.2.1 Effective in scar removal and wound healing 98
TABLE 27 NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99
6.2.1.2 Hydrocolloid dressings 99
6.2.1.2.1 Promotes moist environment required for optimal healing 99
TABLE 28 KEY PRODUCTS IN HYDROCOLLOID DRESSINGS MARKET 100
TABLE 29 HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 100
6.2.1.3 Film dressings 101
6.2.1.3.1 Non-absorbable nature ensures strong adoption 101
TABLE 30 FILM DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 101
6.2.1.4 Alginate dressings 102
6.2.1.4.1 Well-suited for diabetic & foot ulcers 102
TABLE 31 ALGINATE DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
6.2.1.5 Hydrogel dressings 103
6.2.1.5.1 Available in several forms for effective use 103
TABLE 32 HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103
6.2.1.6 Collagen dressings 104
6.2.1.6.1 Help release cytokines and growth factors that expedite wound healing 104
TABLE 33 COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105
6.2.1.7 Hydrofiber dressings 106
6.2.1.7.1 Combine properties of hydrocolloids and collagen 106
TABLE 34 HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106
6.2.1.8 Wound contact layers 107
6.2.1.8.1 Protect wound beds from bacterial and fungal growth 107
TABLE 35 WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107
6.2.1.9 Superabsorbent dressings 108
6.2.1.9.1 Designed for highly exuding wounds 108
TABLE 36 SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 108
6.2.1.10 Other advanced wound dressings 109
TABLE 37 OTHER ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 110
6.2.2 ADVANCED WOUND DRESSINGS, BY PROPERTY 111
TABLE 38 ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION) 111
6.2.2.1 Non-antimicrobial dressings 111
6.2.2.1.1 More cost-effective than antimicrobial alternatives 111
TABLE 39 NON-ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 112
6.2.2.2 Antimicrobial dressings 113
6.2.2.2.1 Provide comprehensive coverage against potential pathogens 113
TABLE 40 ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 113
6.2.3 WOUND THERAPY DEVICES 113
TABLE 41 WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 42 WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114
6.2.3.1 Portable & conventional negative pressure wound therapy devices 115
6.2.3.1.1 Growing adoption of single-use NPWT devices in home care settings to drive market 115
TABLE 43 PORTABLE & CONVENTIONAL NPWT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 116
6.2.3.2 Debridement devices & accessories 116
6.2.3.2.1 Development of novel technologies to support market growth 116
TABLE 44 DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 117
6.2.3.3 Wound assessment & monitoring devices 117
6.2.3.3.1 Potential cost-reducing capabilities to boost adoption 117
TABLE 45 WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 118
6.2.3.4 Other devices & accessories 119
TABLE 46 OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 120
6.2.4 BIOLOGICAL SKIN SUBSTITUTES 121
TABLE 47 KEY PRODUCTS IN BIOLOGICAL SKIN SUBSTITUTES MARKET 121
TABLE 48 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 49 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 122
6.2.4.1 Human donor tissue-derived products 123
6.2.4.1.1 High efficacy to support market demand 123
TABLE 50 KEY PRODUCTS IN HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET 123
TABLE 51 HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 124
6.2.4.2 Acellular animal-derived products 125
6.2.4.2.1 Increasing incidence of diabetic foot ulcers and burn injuries to drive market 125
TABLE 52 KEY PRODUCTS IN ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET 125
TABLE 53 ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 126
6.2.4.3 Biosynthetic products 126
6.2.4.3.1 Increased incidence of infected wounds to support market growth 126
TABLE 54 BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127
6.2.5 TOPICAL AGENTS 127
6.2.5.1 Cost-effectiveness and ease-of-use in home care settings to drive growth 127
TABLE 55 TOPICAL AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 128
6.3 SURGICAL WOUND CARE PRODUCTS 128
TABLE 56 SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 57 SURGICAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 129
6.3.1 SUTURES 130
6.3.1.1 High tensile strength to drive adoption 130
TABLE 58 SUTURES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 131
6.3.2 TISSUE ADHESIVES, SEALANTS, AND GLUES 132
TABLE 59 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION) 132
TABLE 60 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
6.3.2.1 Fibrin-based sealants 133
6.3.2.1.1 Provide better results than sutures 133
TABLE 61 FIBRIN-BASED SEALANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134
6.3.2.2 Synthetic adhesives 135
6.3.2.2.1 Additional sealing properties than traditional staples 135
TABLE 62 SYNTHETIC ADHESIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135
6.3.2.3 Collagen-based sealants 136
6.3.2.3.1 Used in surgical procedures as adjuncts to hemostatic agents 136
TABLE 63 COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 136
6.3.3 STAPLERS 137
6.3.3.1 Faster and more accurate than suturing 137
TABLE 64 STAPLERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 137
6.4 TRADITIONAL WOUND CARE PRODUCTS 138
TABLE 65 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 66 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139
6.4.1 MEDICAL TAPES 140
6.4.1.1 Used for primary wound treatment to cover and secure wounds 140
TABLE 67 MEDICAL TAPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 140
6.4.2 DRESSINGS 141
6.4.2.1 Presence of large patient population for pressure ulcers to drive market 141
TABLE 68 DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141
6.4.3 CLEANSING AGENTS 142
6.4.3.1 High risk of HAIs from open wounds to drive market 142
TABLE 69 TYPES OF CLEANSING AGENTS 142
TABLE 70 CLEANSING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 143
7 WOUND CARE MARKET, BY WOUND TYPE 144
7.1 INTRODUCTION 145
TABLE 71 WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION) 145
7.2 ACUTE WOUNDS 145
TABLE 72 WOUND CARE MARKET FOR ACUTE WOUNDS, BY TYPE, 2021–2028 (USD MILLION) 145
TABLE 73 WOUND CARE MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2021–2028 (USD MILLION) 146
7.2.1 SURGICAL & TRAUMATIC WOUNDS 146
7.2.1.1 Rising volume of surgical procedures to drive market 146
TABLE 74 WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2021–2028 (USD MILLION) 148
7.2.2 BURNS 148
7.2.2.1 High incidence of burn injuries to drive market 148
TABLE 75 WOUND CARE MARKET FOR BURNS, BY COUNTRY, 2021–2028 (USD MILLION) 149
7.3 CHRONIC WOUNDS 150
TABLE 76 WOUND CARE MARKET FOR CHRONIC WOUNDS, BY TYPE, 2021–2028 (USD MILLION) 150
TABLE 77 WOUND CARE MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2021–2028 (USD MILLION) 151
7.3.1 DIABETIC FOOT ULCERS 151
7.3.1.1 Increasing prevalence of diabetes to support market growth 151
TABLE 78 TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE (20–79 AGE GROUP), 2021 152
TABLE 79 WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2021–2028 (USD MILLION) 153
7.3.2 PRESSURE ULCERS 154
7.3.2.1 Growing geriatric population to aid market growth 154
TABLE 80 WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2021–2028 (USD MILLION) 155
7.3.3 VENOUS LEG ULCERS 155
7.3.3.1 Rising prevalence of obesity to drive market 155
TABLE 81 WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2021–2028 (USD MILLION) 156
7.3.4 OTHER CHRONIC WOUNDS 157
TABLE 82 COMMERCIALLY AVAILABLE WOUND CARE BIOLOGIC PRODUCTS FOR OTHER CHRONIC WOUNDS 157
TABLE 83 WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2021–2028 (USD MILLION) 158
8 WOUND CARE MARKET, BY END USER 159
8.1 INTRODUCTION 160
TABLE 84 WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 160
8.2 HOSPITALS & CLINICS 160
TABLE 85 TOTAL NUMBER OF HOSPITALS, BY COUNTRY, 2021 161
TABLE 86 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2021–2028 (USD MILLION) 162
TABLE 87 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION) 162
8.2.1 INPATIENT SETTINGS 163
8.2.1.1 Increasing hospital admissions due to HAIs to drive market 163
TABLE 88 WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION) 163
8.2.2 OUTPATIENT SETTINGS 164
8.2.2.1 Rising cost of inpatient facilities to increase demand for outpatient care settings 164
TABLE 89 WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION) 164
8.3 HOME CARE SETTINGS 165
8.3.1 LOW COST AND CONVENIENCE TO SUPPORT MARKET GROWTH 165
TABLE 90 WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION) 166
8.4 LONG-TERM CARE FACILITIES 166
8.4.1 GROWING GERIATRIC POPULATION TO INCREASE DEMAND FOR BETTER LONG-TERM CARE 166
TABLE 91 WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2021–2028 (USD MILLION) 167
8.5 OTHER END USERS 167
TABLE 92 WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 168
9 WOUND CARE MARKET, BY REGION 169
9.1 INTRODUCTIONS 170
TABLE 93 WOUND CARE MARKET, BY REGION, 2021–2028 (USD MILLION) 170
9.2 NORTH AMERICA 170
FIGURE 25 NORTH AMERICA: WOUND CARE MARKET SNAPSHOT 171
TABLE 94 NORTH AMERICA: WOUND CARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 172
TABLE 95 NORTH AMERICA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 172
TABLE 96 NORTH AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 97 NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 98 NORTH AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 173
TABLE 99 NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION) 174
TABLE 100 NORTH AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 174
TABLE 101 NORTH AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 102 NORTH AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 103 NORTH AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 104 NORTH AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 176
TABLE 105 NORTH AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION) 176
TABLE 106 NORTH AMERICA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 176
9.2.1 RECESSION IMPACT ON NORTH AMERICAN WOUND CARE MARKET 177
9.2.2 US 177
9.2.2.1 Rising incidence of chronic diseases and diabetes to drive market 177
TABLE 107 US: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 178
TABLE 108 US: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 178
9.2.3 CANADA 178
9.2.3.1 High prevalence of HAIs to support market growth 178
TABLE 109 CANADA: INCIDENCE OF DIABETES, 2022 VS. 2032 179
TABLE 110 CANADA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 180
TABLE 111 CANADA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 180
9.3 EUROPE 180
TABLE 112 EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP), 2022 181
TABLE 113 EUROPE: PREVALENCE OF DIABETES, 2021 VS. 2045 182
TABLE 114 EUROPE: WOUND CARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 182
TABLE 115 EUROPE: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 182
TABLE 116 EUROPE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 117 EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 183
TABLE 118 EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 119 EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION) 184
TABLE 120 EUROPE: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 184
TABLE 121 EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 122 EUROPE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 123 EUROPE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION) 185
TABLE 124 EUROPE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 186
TABLE 125 EUROPE: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION) 186
TABLE 126 EUROPE: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 186
9.3.1 RECESSION IMPACT ON EUROPEAN WOUND CARE MARKET 187
9.3.2 GERMANY 187
9.3.2.1 Large diabetic population to support wound care product development and commercialization 187
TABLE 127 GERMANY: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 188
TABLE 128 GERMANY: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 188
9.3.3 FRANCE 188
9.3.3.1 Rising geriatric population to drive market growth 188
TABLE 129 FRANCE: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 189
TABLE 130 FRANCE: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 189
9.3.4 UK 189
9.3.4.1 Rising incidence of chronic wounds to propel market growth 189
TABLE 131 UK: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 190
TABLE 132 UK: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 190
9.3.5 ITALY 190
9.3.5.1 Improving quality and accessibility to medical care to support market growth 190
TABLE 133 ITALY: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 191
TABLE 134 ITALY: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 191
9.3.6 SPAIN 192
9.3.6.1 Increasing number of road traffic accidents to propel market 192
TABLE 135 SPAIN: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 192
TABLE 136 SPAIN: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 193
9.3.7 RUSSIA 193
9.3.7.1 Government focus on increasing diabetes awareness to favor market growth 193
TABLE 137 RUSSIA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 194
TABLE 138 RUSSIA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 194
9.3.8 REST OF EUROPE 194
TABLE 139 REST OF EUROPE: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 195
TABLE 140 REST OF EUROPE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 195
TABLE 141 REST OF EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 142 REST OF EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 196
TABLE 143 REST OF EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION) 197
TABLE 144 REST OF EUROPE: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 197
TABLE 145 REST OF EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 146 REST OF EUROPE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 147 REST OF EUROPE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION) 198
TABLE 148 REST OF EUROPE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 199
TABLE 149 REST OF EUROPE: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION) 199
TABLE 150 REST OF EUROPE: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 199
9.4 ASIA PACIFIC 200
FIGURE 26 ASIA PACIFIC: WOUND CARE MARKET SNAPSHOT 201
TABLE 151 ASIA PACIFIC: WOUND CARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 202
TABLE 152 ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 202
TABLE 153 ASIA PACIFIC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 202
TABLE 154 ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 155 ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 203
TABLE 156 ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION) 204
TABLE 157 ASIA PACIFIC: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 158 ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION) 204
TABLE 159 ASIA PACIFIC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 160 ASIA PACIFIC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 161 ASIA PACIFIC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 205
TABLE 162 ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION) 206
TABLE 163 ASIA PACIFIC: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 206
9.4.1 RECESSION IMPACT ON ASIA PACIFIC WOUND CARE MARKET 206
9.4.2 CHINA 206
9.4.2.1 Increasing incidence of diabetic foot ulcers to drive market 206
TABLE 164 CHINA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 207
TABLE 165 CHINA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 207
9.4.3 JAPAN 208
9.4.3.1 Presence of well-developed healthcare system to favor market growth 208
TABLE 166 JAPAN: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 208
TABLE 167 JAPAN: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 209
9.4.4 INDIA 209
9.4.4.1 Growing medical tourism to support market growth 209
TABLE 168 INDIA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 210
TABLE 169 INDIA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 210
9.4.5 AUSTRALIA 210
9.4.5.1 Increasing initiatives to spread awareness of effective wound care to propel market 210
TABLE 170 AUSTRALIA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 211
TABLE 171 AUSTRALIA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 211
9.4.6 SOUTH KOREA 211
9.4.6.1 Rising geriatric population to aid market growth 211
TABLE 172 SOUTH KOREA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 212
TABLE 173 SOUTH KOREA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 212
9.4.7 SINGAPORE 212
9.4.7.1 Growing prevalence of diabetes to support market growth 212
TABLE 174 SINGAPORE: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 213
TABLE 175 SINGAPORE: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 213
9.4.8 REST OF ASIA PACIFIC 213
TABLE 176 REST OF ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 214
TABLE 177 REST OF ASIA PACIFIC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 214
TABLE 178 REST OF ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 179 REST OF ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 215
TABLE 180 REST OF ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION) 216
TABLE 181 REST OF ASIA PACIFIC: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 182 REST OF ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION) 216
TABLE 183 REST OF ASIA PACIFIC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 184 REST OF ASIA PACIFIC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 185 REST OF ASIA PACIFIC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 217
TABLE 186 REST OF ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION) 218
TABLE 187 REST OF ASIA PACIFIC: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 218
9.5 LATIN AMERICA 218
TABLE 188 LATIN AMERICA: WOUND CARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 219
TABLE 189 LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 219
TABLE 190 LATIN AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 191 LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 220
TABLE 192 LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 193 LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION) 221
TABLE 194 LATIN AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 221
TABLE 195 LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 196 LATIN AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 197 LATIN AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION) 222
TABLE 198 LATIN AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 223
TABLE 199 LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION) 223
TABLE 200 LATIN AMERICA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 223
9.5.1 RECESSION IMPACT ON LATIN AMERICAN WOUND CARE MARKET 224
9.5.2 BRAZIL 224
9.5.2.1 Largest healthcare market in Latin America 224
TABLE 201 BRAZIL: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 224
TABLE 202 BRAZIL: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 225
9.5.3 MEXICO 225
9.5.3.1 Increasing burden of diabetes to propel market 225
TABLE 203 MEXICO: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 225
TABLE 204 MEXICO: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 226
9.5.4 REST OF LATIN AMERICA 226
TABLE 205 REST OF LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 226
TABLE 206 REST OF LATIN AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 207 REST OF LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 227
TABLE 208 REST OF LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 209 REST OF LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION) 228
TABLE 210 REST OF LATIN AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 228
TABLE 211 REST OF LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 212 REST OF LATIN AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 213 REST OF LATIN AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION) 229
TABLE 214 REST OF LATIN AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 230
TABLE 215 REST OF LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION) 230
TABLE 216 REST OF LATIN AMERICA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 230
9.6 MIDDLE EAST & AFRICA 231
9.6.1 RISING PREVALENCE OF DIABETES TO SUPPORT MARKET GROWTH 231
TABLE 217 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 231
TABLE 218 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 219 MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 232
TABLE 220 MIDDLE EAST & AFRICA: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 221 MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION) 233
TABLE 222 MIDDLE EAST & AFRICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 233
TABLE 223 MIDDLE EAST & AFRICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 224 MIDDLE EAST & AFRICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 225 MIDDLE EAST & AFRICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION) 234
TABLE 226 MIDDLE EAST & AFRICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION) 235
TABLE 227 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION) 235
TABLE 228 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 235
9.6.2 RECESSION IMPACT ON MIDDLE EAST & AFRICAN WOUND CARE MARKET 236
10.1 OVERVIEW 237
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 237
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN WOUND CARE MARKET 238
TABLE 229 OVERVIEW OF STRATEGIES ADOPTED BY KEY WOUND CARE COMPANIES 238
10.3 REVENUE ANALYSIS OF TOP MARKET PLAYERS 240
FIGURE 27 REVENUE ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET, 2018–2022 (USD MILLION) 240
10.4 MARKET SHARE ANALYSIS 241
10.4.1 WOUND CARE MARKET 241
FIGURE 28 WOUND CARE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 241
TABLE 230 WOUND CARE MARKET: DEGREE OF COMPETITION 241
10.4.2 ADVANCED WOUND CARE MARKET 242
FIGURE 29 ADVANCED WOUND CARE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 242
10.4.3 NEGATIVE PRESSURE WOUND THERAPY (NPWT) MARKET 243
FIGURE 30 NEGATIVE PRESSURE WOUND THERAPY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 243
10.4.4 ADVANCED WOUND DRESSINGS MARKET 243
FIGURE 31 ADVANCED WOUND DRESSINGS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 243
10.4.5 SURGICAL SUTURES MARKET 244
FIGURE 32 SURGICAL SUTURES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 244
10.4.6 DEBRIDEMENT DEVICES MARKET 244
FIGURE 33 DEBRIDEMENT DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022 244
10.4.7 TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET 245
TABLE 231 TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET RANKING ANALYSIS, BY KEY PLAYER, 2022 245
10.5 COMPANY EVALUATION MATRIX 245
10.5.1 LIST OF EVALUATED VENDORS 245
10.5.2 STARS 245
10.5.3 EMERGING LEADERS 245
10.5.4 PERVASIVE PLAYERS 245
10.5.5 PARTICIPANTS 246
FIGURE 34 WOUND CARE MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 246
10.5.6 COMPANY FOOTPRINT 247
FIGURE 35 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET 247
TABLE 232 PRODUCT FOOTPRINT ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET 247
TABLE 233 REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET 247
10.6 STARTUP/SME EVALUATION MATRIX 248
10.6.1 PROGRESSIVE COMPANIES 248
10.6.2 RESPONSIVE COMPANIES 248
10.6.3 DYNAMIC COMPANIES 248
10.6.4 STARTING BLOCKS 248
FIGURE 36 WOUND CARE MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022 249
10.6.5 COMPETITIVE BENCHMARKING 250
TABLE 234 WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS 250
TABLE 235 WOUND CARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 250
10.7 COMPETITIVE SCENARIO 251
10.7.1 PRODUCT LAUNCHES 251
TABLE 236 KEY PRODUCT LAUNCHES 251
10.7.2 DEALS 252
TABLE 237 KEY DEALS 252
11 COMPANY PROFILES 253
11.1 KEY PLAYERS 253
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 3M COMPANY 253
TABLE 238 3M COMPANY: COMPANY OVERVIEW 253
FIGURE 37 3M COMPANY: COMPANY SNAPSHOT (2022) 254
11.1.2 CARDINAL HEALTH 260
TABLE 239 CARDINAL HEALTH: COMPANY OVERVIEW 260
FIGURE 38 CARDINAL HEALTH: COMPANY SNAPSHOT (2022) 261
11.1.3 MEDTRONIC PLC 266
TABLE 240 MEDTRONIC PLC: COMPANY OVERVIEW 266
FIGURE 39 MEDTRONIC PLC: COMPANY SNAPSHOT (2022) 267
11.1.4 SMITH & NEPHEW PLC 271
TABLE 241 SMITH & NEPHEW PLC: COMPANY OVERVIEW 271
FIGURE 40 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2022) 272
11.1.5 MÖLNLYCKE HEALTH CARE AB 278
TABLE 242 MÖLNLYCKE HEALTH CARE AB: COMPANY OVERVIEW 278
FIGURE 41 MÖLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT (2022) 279
11.1.6 B. BRAUN MELSUNGEN AG 282
TABLE 243 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 282
FIGURE 42 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022) 283
11.1.7 BAXTER INTERNATIONAL, INC. 285
TABLE 244 BAXTER INTERNATIONAL, INC.: COMPANY OVERVIEW 285
FIGURE 43 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022) 286
11.1.8 CONVATEC GROUP PLC 288
TABLE 245 CONVATEC GROUP PLC: COMPANY OVERVIEW 288
FIGURE 44 CONVATEC GROUP: COMPANY SNAPSHOT (2022) 289
11.1.9 PAUL HARTMANN AG 292
TABLE 246 PAUL HARTMANN AG: COMPANY OVERVIEW 292
FIGURE 45 PAUL HARTMANN AG: COMPANY SNAPSHOT (2022) 293
11.1.10 COLOPLAST A/S 296
TABLE 247 COLOPLAST A/S: COMPANY OVERVIEW 296
FIGURE 46 COLOPLAST A/S: COMPANY SNAPSHOT (2022) 297
11.1.11 ORGANOGENESIS INC. 299
TABLE 248 ORGANOGENESIS INC.: COMPANY OVERVIEW 299
FIGURE 47 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2022) 300
11.1.12 MIMEDX GROUP, INC. 302
TABLE 249 MIMEDX GROUP, INC.: COMPANY OVERVIEW 302
FIGURE 48 MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2022) 302
11.1.13 INTEGRA LIFESCIENCES CORPORATION 305
TABLE 250 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 305
FIGURE 49 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022) 306
11.1.14 BIOVENTUS LLC 309
TABLE 251 BIOVENTUS LLC: COMPANY OVERVIEW 309
FIGURE 50 BIOVENTUS LLC: COMPANY SNAPSHOT (2022) 310
11.1.15 ZIMMER BIOMET HOLDINGS, INC. 312
TABLE 252 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW 312
FIGURE 51 ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT (2022) 313
11.2 OTHER PLAYERS 315
11.2.1 ETHICON, INC. 315
TABLE 253 ETHICON, INC.: COMPANY OVERVIEW 315
11.2.2 DEROYAL INDUSTRIES, INC. 316
TABLE 254 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW 316
11.2.3 KERECIS 318
TABLE 255 KERECIS: COMPANY OVERVIEW 318
11.2.4 ACELL INC. 319
TABLE 256 ACELL INC.: COMPANY OVERVIEW 319
11.2.5 LOHMANN & RAUSCHER GMBH & CO. KG 320
TABLE 257 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW 320
11.2.6 MEDELA AG 322
TABLE 258 MEDELA AG: COMPANY OVERVIEW 322
11.2.7 TALLEY GROUP LTD. 322
TABLE 259 TALLEY GROUP LTD.: COMPANY OVERVIEW 322
11.2.8 WELCARE INDUSTRIES S.P.A 323
TABLE 260 WELCARE INDUSTRIES S.P.A: COMPANY OVERVIEW 323
11.2.9 WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD. 323
TABLE 261 WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 323
11.2.10 PENSAR MEDICAL, LLC 324
TABLE 262 PENSAR MEDICAL, LLC: COMPANY OVERVIEW 324
11.2.11 HAROMED BV 325
TABLE 263 HAROMED BV: COMPANY OVERVIEW 325
11.2.12 DERMARITE INDUSTRIES, LLC 326
TABLE 264 DERMARITE INDUSTRIES, LLC: COMPANY OVERVIEW 326
11.2.13 MEDLINE INDUSTRIES, INC. 327
TABLE 265 MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW 327
11.2.14 ADVANCIS MEDICAL LLC 330
TABLE 266 ADVANCIS MEDICAL LLC: COMPANY OVERVIEW 330
11.2.15 MIL LABORATORIES PVT. LTD. 331
TABLE 267 MIL LABORATORIES PVT. LTD.: COMPANY OVERVIEW 331
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 332
12.1 DISCUSSION GUIDE 332
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 337
12.3 CUSTOMIZATION OPTIONS 339
12.4 RELATED REPORTS 339
12.5 AUTHOR DETAILS 340
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
